US · INGN
Inogen, Inc.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Goleta, CA 93117
- Website
- inogen.com
Price · as of 2025-12-31
$6.98
Market cap 165.61M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $177.94 | +2,449.28% |
| Intrinsic Value(DCF) | $3.26 | -53.3% |
| Graham-Dodd Method(GD) | $2.50 | -64.26% |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | $2.16 | $2.49 | |||
| 2013 | $19.19 | $144.47 | $1,512.87 | $10.16 | $86.13 |
| 2014 | $32.49 | $91.65 | $1,692.41 | $9.41 | $23.28 |
| 2015 | $34.28 | $69.95 | $1,222.22 | $9.89 | $28.39 |
| 2016 | $71.43 | $87.23 | $558.04 | $14.19 | $35.31 |
| 2017 | $125.46 | $106.13 | $316.42 | $15.94 | $30.59 |
| 2018 | $93.95 | $94.95 | $935.42 | $25.20 | $114.76 |
| 2019 | $44.52 | $86.74 | $133.43 | $19.08 | $8.72 |
| 2020 | $51.62 | $68.92 | $6.68 | $13.07 | $1.60 |
| 2021 | $29.80 | $72.99 | $7.97 | $13.59 | $0.00 |
| 2022 | $13.47 | $171.55 | $0.00 | $0.00 | $0.00 |
| 2023 | $7.59 | $58.77 | $0.00 | $0.00 | $33.40 |
| 2024 | $7.76 | $204.05 | $0.60 | $0.00 | $0.00 |
| 2025 | $6.18 | $177.94 | $1.22 | $2.50 | $0.00 |
AI valuation
Our deep-learning model estimates Inogen, Inc.'s (INGN) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $177.94
- Current price
- $6.98
- AI upside
- +2,449.28%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$3.26
-53.3% upside
Graham-Dodd
$2.50
-64.26% upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| INGN | Inogen, Inc. | $6.98 | 165.61M | +2,449% | -53% | -64% | — | -7.38 | 0.87 | 0.48 | -24.21 | — | 1.11 | 47.58% | -8.66% | -6.52% | -12.43% | -34.66% | -7.65% | 0.09 | — | 3.12 | 2.49 | 31.71 | -4408.00% | 386.00% | 9321.00% | -12.86% | -0.18 | -25.47% | 0.00% | 0.00% | 0.00% | -2.18 | -3.05 | 0.19 | 1.50 |
| EPRX | Eupraxia Pharmaceuticals … | $8.18 | 273.87M | — | — | — | — | -5.48 | 4.23 | — | -3.01 | — | 4.23 | 0.00% | — | — | -144.55% | 1233.17% | -93.26% | 0.00 | -44.74 | 11.10 | 10.74 | 0.92 | -3504.00% | — | 4455.00% | -21.32% | -9.67 | 955.80% | 0.00% | 0.00% | 17.10% | -2.78 | -3.59 | — | 19.45 |
| HCAT | Health Catalyst, Inc. | $1.62 | 114.58M | +1,831% | +136% | — | — | -3.71 | 0.71 | 0.84 | -25.20 | — | 13.31 | 45.92% | -22.77% | -22.67% | -18.99% | -20.72% | -8.91% | 1.10 | -4.09 | 1.43 | 1.38 | -14.33 | -4498.00% | 360.00% | -9612.00% | -0.71% | 0.04 | -0.55% | 0.00% | 0.00% | 0.00% | -3.85 | -145.98 | 0.88 | -1.34 |
| HSDT | Solana Company | $1.87 | 75.36M | +7,559% | +13,131% | — | +2,272% | -77.89 | 863.60 | 1758.75 | -66.18 | — | 863.60 | -11.92% | -2673.65% | -2258.08% | -688.88% | 995.92% | -209.04% | 0.01 | -817.82 | 1.58 | 0.80 | 0.08 | -4052.00% | -1925.00% | 575.00% | -1.21% | -5.10 | 791.26% | 0.00% | 0.00% | 0.00% | -65.70 | -82.70 | 1756.68 | 140.75 |
| NNOX | Nano-X Imaging Ltd. | $2.37 | 151.12M | +990% | +2% | — | — | -6.62 | 1.87 | 31.38 | -6.41 | — | 2.97 | -94.03% | -502.93% | -474.31% | -27.83% | -46.04% | -24.97% | 0.04 | — | 5.63 | 5.37 | 0.71 | -1574.00% | 1391.00% | -1813.00% | -11.12% | -2.62 | -32.15% | 0.00% | 0.00% | 0.00% | -5.08 | -7.32 | 25.55 | 7.21 |
| OM | Outset Medical, Inc. | $3.49 | 63.91M | +1,299% | -32% | — | — | — | 0.43 | 0.45 | 0.16 | — | 0.43 | 39.13% | -55.84% | -68.34% | 0.00% | -100.69% | 0.00% | 0.82 | -4.78 | 6.67 | 5.24 | -1.11 | -8547.00% | 509.00% | -5980.00% | -86.78% | -1.23 | -71.12% | 0.00% | — | 15.34% | 0.15 | 0.21 | -0.08 | -5.38 |
| QTRX | Quanterix Corporation | $6.55 | 305.96M | +237% | -22% | -45% | — | -7.37 | 0.86 | 2.10 | -0.73 | -45.26 | 0.87 | 59.89% | -38.85% | -28.45% | -11.33% | -70.92% | -9.23% | 0.11 | — | 8.66 | 7.65 | 0.44 | 1628.00% | 1180.00% | 6982.00% | -13.57% | -0.84 | -51.94% | 0.00% | 0.00% | 0.00% | -0.61 | -0.83 | 0.24 | 1.46 |
| SGHT | Sight Sciences, Inc. | $5.16 | 272.82M | +483% | -76% | — | — | -2.30 | 1.35 | 1.48 | -0.83 | — | 1.35 | 85.50% | -63.27% | -64.49% | -49.59% | -403.80% | -33.29% | 0.46 | -10.84 | 9.04 | 8.48 | 1.74 | -965.00% | -147.00% | -5261.00% | -19.22% | -1.44 | -181.68% | 0.00% | 0.00% | 0.00% | -0.76 | -1.69 | 0.48 | -1.67 |
| SI | SHOULDER INNOVATIONS, INC… | $13.56 | 279.36M | — | — | — | — | — | — | — | — | — | — | 76.97% | -46.34% | -49.39% | -57.30% | -81.73% | -32.08% | 0.74 | -11.13 | 4.59 | 2.64 | -0.71 | 2222.00% | 6407.00% | 1426.00% | — | -1.85 | -101.28% | — | 0.00% | — | — | — | — | — |
| SNWV | SANUWAVE Health, Inc. | $24.33 | 208.62M | +2,106% | +2,696% | — | — | -4.13 | -10.18 | 3.97 | -8.74 | — | -5.46 | 75.23% | 16.60% | -96.13% | 112.25% | -90.44% | -119.43% | -2.00 | 0.40 | 0.43 | 0.32 | -0.92 | -4233.00% | 5999.00% | -14330.00% | 1.52% | 0.06 | -32.81% | 0.00% | 0.00% | 10.35% | 26.71 | 73.63 | 4.43 | -9.15 |
About Inogen, Inc.
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
- CEO
- Kevin R. Smith
- Employees
- 766
- Beta
- 1.79
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($3.26 ÷ $6.98) − 1 = -53.3% (DCF, example).